Psoriasis is frequently seen in older patients and systemic treatment is often indicated. Randomized controlled trials (RCTs) generally maintain strict in- and exclusion criteria, which might lead to a disproportionally high exclusion rate of older adults.
Continue Reading→Despite the availability of different therapeutic modalities, treatment of recalcitrant common warts is still challenging. Cervarix, a recombinant bivalent human papillomavirus (HPV) vaccine, has shown promising efficacy in the treatment of warts.
Continue Reading→